Advertisement
Canada markets closed
  • S&P/TSX

    21,947.41
    +124.21 (+0.57%)
     
  • S&P 500

    5,127.79
    +63.59 (+1.26%)
     
  • DOW

    38,675.68
    +449.98 (+1.18%)
     
  • CAD/USD

    0.7312
    +0.0004 (+0.05%)
     
  • CRUDE OIL

    78.40
    +0.29 (+0.37%)
     
  • Bitcoin CAD

    87,821.97
    +1,203.84 (+1.39%)
     
  • CMC Crypto 200

    1,333.95
    +56.97 (+4.46%)
     
  • GOLD FUTURES

    2,323.20
    +14.60 (+0.63%)
     
  • RUSSELL 2000

    2,035.72
    +19.61 (+0.97%)
     
  • 10-Yr Bond

    4.5000
    -0.0710 (-1.55%)
     
  • NASDAQ futures

    18,012.25
    +11.50 (+0.06%)
     
  • VOLATILITY

    13.49
    -1.19 (-8.11%)
     
  • FTSE

    8,213.49
    +41.34 (+0.51%)
     
  • NIKKEI 225

    38,236.07
    -38.03 (-0.10%)
     
  • CAD/EUR

    0.6786
    -0.0001 (-0.01%)
     

Arq, Inc. (NASDAQ:ARQ) Q4 2023 Earnings Call Transcript

Arq, Inc. (NASDAQ:ARQ) Q4 2023 Earnings Call Transcript March 13, 2024

Arq, Inc. isn't one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).

Operator: Greetings. Welcome to Arq's Fourth Quarter and Full Year 2023 Earnings Call. At this time all participants will be in listen only mode. A question-and-answer session will follow the formal presentation [Operator Instructions]. Please note this conference is being recorded. I'll now turn the call over to Ryan Coleman with Investor Relations. Thank you. You may now begin.

Ryan Coleman: Thank you, operator. Good morning, everyone. And thank you for joining us today for our fourth quarter and full year 2023 earnings results call. With me on the call today are Bob Rasmus, Arq's Chief Executive Officer and President; as well as Kim Hansen, Arq's VP of Finance. This conference call is being webcasted live within the Investors section of our Web site and a downloadable version of today's presentation is available there as well. A webcast replay will also be available on our site and you can contact Arq's Investor Relations team at investor@arq.com. Let me remind you that the presentation and remarks made today include forward-looking statements as defined in Section 21E of the Securities Exchange Act.

A scientist surrounded by a laboratory of chemicals and beakers, developing small molecular therapies.

ADVERTISEMENT

These statements are based on information currently available to us and involve risks and uncertainties that could cause actual future results, performance and business prospects and opportunities to differ materially from those expressed in or implied by these statements. These risks and uncertainties include, but are not limited to, those factors identified on Slide 2 of today's slide presentation, in our Form 10-K for the year ended December 31, 2023 and other filings with the Securities and Exchange Commission. Except as expressly required by securities laws, the company undertakes no obligation to update those factors or any forward-looking statements to reflect future events developments or changed circumstances or for any other reason.

In addition, it is especially important to review the presentation in today's remarks in conjunction with the GAAP references in the financial statements. With that, I would like to turn the call over to Bob.

Bob Rasmus: Thank you, Ryan. And thanks to everyone for joining us this morning. Let's begin on Slide 3 of our presentation. We finished 2023 with strong momentum and are very pleased with the steps we have taken and continue to take to further improve our business. Our fourth quarter results clearly indicate the improving profitability of our existing business. We delivered a very solid quarter marked by revenue growth of 20% over the prior year, nearly doubled our gross margin to approximately 50% versus last year, generated strong cash flow from our PAC business in the form of $7.2 million of adjusted EBITDA, and we are excited to have achieved positive net income for the first time in eight quarters. As I have emphasized since joining, our absolute focus is on execution and maximizing shareholder value.

See also 10 Biggest Stocks Targeted By Activist Investors Right Now and 27 Most Charitable Countries in the World.

To continue reading the Q&A session, please click here.